Tropical Health Department, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt.
Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan.
Int J Environ Res Public Health. 2023 Feb 1;20(3):2640. doi: 10.3390/ijerph20032640.
Despite national programs covering the cost of treatment for tuberculosis (TB) in many countries, TB patients still face substantial costs. The end TB strategy, set by the World Health Organization (WHO), calls for "zero" TB households to be affected by catastrophic payments by 2025. This study aimed to measure the catastrophic healthcare payments among TB patients in Egypt, to determine its cost drivers and determinants and to describe the coping strategies. The study utilized an Arabic-validated version of the TB cost tool developed by the WHO for estimating catastrophic healthcare expenditure using the cluster-based sample survey with stratification in seven administrative regions in Alexandria. TB payments were considered catastrophic if the total cost exceeded 20% of the household's annual income. A total of 276 patients were interviewed: 76.4% were males, 50.0% were in the age group 18-35, and 8.3% had multidrug-resistant TB. Using the human capital approach, 17.0% of households encountered catastrophic costs compared to 59.1% when using the output approach. The cost calculation was carried out using the Egyptian pound converted to the United States dollars based on 2021 currency values. Total TB cost was United States dollars (USD) 280.28 ± 29.9 with a total direct cost of USD 103 ± 10.9 and a total indirect cost of USD 194.15 ± 25.5. The direct medical cost was the main cost driver in the pre-diagnosis period (USD 150.23 ± 26.89 pre diagnosis compared to USD 77.25 ± 9.91 post diagnosis, = 0.013). The indirect costs (costs due to lost productivity) were the main cost driver in the post-diagnosis period (USD 4.68 ± 1.18 pre diagnosis compared to USD 192.84 ± 25.32 post diagnosis, < 0.001). The households drew on multiple financial strategies to cope with TB costs where 66.7% borrowed and 25.4% sold household property. About two-thirds lost their jobs and another two-thirds lowered their food intake. Being female, delay in diagnosis and being in the intensive phase were significant predictors of catastrophic payment. Catastrophic costs were high among TB households in Alexandria and showed wide variation according to the method used for indirect cost estimation. The main cost driver before diagnosis was the direct medical costs, while it was the indirect costs, post diagnosis.
尽管许多国家都有国家项目来支付结核病(TB)的治疗费用,但结核病患者仍然面临着巨大的费用负担。世界卫生组织(WHO)制定的终结结核病战略呼吁到 2025 年,使“零”结核病家庭免受灾难性医疗支出的影响。本研究旨在衡量埃及结核病患者的灾难性医疗支出,确定其成本驱动因素和决定因素,并描述应对策略。该研究使用了世卫组织开发的经阿拉伯语验证的结核病成本工具的阿拉伯语版本,该工具用于使用基于聚类的样本调查,在亚历山大的七个行政区进行分层,以估计灾难性的医疗支出。如果总费用超过家庭年收入的 20%,则认为结核病支付是灾难性的。共访谈了 276 名患者:76.4%为男性,50.0%年龄在 18-35 岁之间,8.3%患有耐多药结核病。使用人力资本方法,17.0%的家庭遭遇灾难性支出,而使用产出方法则有 59.1%的家庭遭遇灾难性支出。成本计算是根据 2021 年的货币价值,使用埃及镑换算成美元进行的。结核病总费用为 280.28 美元,其中直接总费用为 103 美元,间接总费用为 194.15 美元。直接医疗费用是诊断前期间的主要费用驱动因素(诊断前为 150.23 美元,诊断后为 77.25 美元, = 0.013)。间接费用(由于生产力损失而产生的费用)是诊断后期间的主要费用驱动因素(诊断前为 4.68 美元,诊断后为 192.84 美元, < 0.001)。家庭采用多种财务策略来应对结核病费用,其中 66.7%的家庭借款,25.4%的家庭出售家庭财产。大约三分之二的人失业,另有三分之二的人减少了食物摄入量。女性、诊断延迟和处于强化期是灾难性支付的显著预测因素。亚历山大的结核病家庭的灾难性费用很高,根据间接费用估算方法的不同,差异很大。诊断前的主要费用驱动因素是直接医疗费用,而诊断后的主要费用驱动因素是间接费用。